Skip to main content
Explore URMC

menu
URMC / Research / Research@URMC / September 2016

September 2016

New Technologies May Speed Flu Vaccine Testing

New Technologies May Speed Flu Vaccine Testing

The AIR™ Platform, a silicon chip and imaging system marketed by Adarza Biosystems, can detect immune responses to flu virus and vaccines alike.  With a small blood sample, doctors can confirm a suspected flu infection, see if a vaccine induces a desired immune response, or predict which strains of flu will affect people in the coming flu season.